Breaking News on Contract Research, Manufacturing & Clinical Trials

Headlines > Clinical Development

News in brief

Celerion joins capability cluster to boost patient access


Celerion has improved access to patients with respiratory diseases by joining a UK capability cluster.

Joining the UK respiratory therapeutic capability cluster gives Celerion’s Northern Ireland site access to patients for Phase I trials.

We have seen an increasing demand for conducting Phase I studies in patients with access to more specialised techniques. This collaboration allows Celerion to address this need and assist clients to gain insight to data earlier”, said Phil Bach, VP of clinical research at Celerion.

Key Industry Events


Access all events listing

Our events, Events from partners...